- Report
- January 2020
- 40 Pages
United States
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 40 Pages
Russia
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 40 Pages
Ireland
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 40 Pages
Germany
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 40 Pages
China
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 40 Pages
Brazil
From €2473EUR$2,595USD£2,122GBP
- Report
- January 2020
- 80 Pages
Africa
From €3617EUR$3,795USD£3,103GBP
- Report
- May 2023
- 140 Pages
Global
From €5718EUR$5,999USD£4,905GBP
- Report
- May 2023
- 147 Pages
Global
From €5718EUR$5,999USD£4,905GBP
The Mono Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent or reduce the severity of infectious diseases. Mono Vaccines are a type of vaccine that protect against a single pathogen, such as measles, mumps, rubella, or varicella. These vaccines are typically administered to children and are often combined with other vaccines to form a combination vaccine. Mono Vaccines are typically administered in a single dose, and are often given in combination with other vaccines to form a combination vaccine.
The Mono Vaccine market is highly competitive, with a number of companies offering products. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Other companies in the market include AstraZeneca, CSL, Emergent BioSolutions, and Johnson & Johnson. Show Less Read more